Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO

08.26.2020 - By FT News Briefing

Download our free app to listen on your phone

European vaccine makers want EU exemptions that would protect them if there are problems with new Covid-19 vaccines, and low interest rates have helped US homebuilder stocks surge to record highs. Plus, the FT’s James Fontanella-Khan explains why Ant Group chose to list its potentially record setting IPO outside the US. 

Covid-19 vaccine makers lobby EU for legal protection

Low rates help propel US homebuilder stocks to record highs

Ant Group reveals $2.6bn profit as it files for blockbuster IPO
 See for privacy and opt-out information.

More episodes from FT News Briefing